The Challenges of Orphan Drugs and Orphan Diseases: Real and Imagined

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|92|2|151-153

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.92, Iss.2, 2012-08, pp. : 151-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orphan Kidney Diseases

By  

Nephron Clin Pract, Vol. 120, Iss. 4, 2012-08 ,pp. : c194-c199

Karger

Access to resources Recommend Favorite

Rare Diseases and Orphan Drugs: A comprehensive approach of strategic perspectives

By Hansen Jan-C閐ric  

Journal of Communication In Healthcare, Vol. 5, Iss. 4, 2012-12 ,pp. : 199-219

Maney Publishing

Access to resources Recommend Favorite

Mechanisms of Pleural Involvement in Orphan Diseases

By  

Respiration, Vol. 83, Iss. 1, 2012-01 ,pp. : 5-12

Karger

Access to resources Recommend Favorite

Orphan drugs: pricing, reimbursement and patient access

By Barak Adam   Nandi Jyoti Shankar  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5, Iss. 4, 2011-11 ,pp. : 299-317

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Gene, Stem Cell, and Future Therapies for Orphan Diseases

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 182-192

John Wiley & Sons Inc

Access to resources Recommend Favorite